Literature DB >> 11232128

Treating acute myocardial infarction.

W D Panton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11232128      PMCID: PMC80717     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Acute myocardial infarction in Canada: improvement with time.

Authors:  A Dodek
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

2.  Rationale and design of the magnesium in coronaries (MAGIC) study: A clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarction.

Authors: 
Journal:  Am Heart J       Date:  2000-01       Impact factor: 4.749

3.  Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995.

Authors:  L Pilote; F Lavoie; V Ho; M J Eisenberg
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

Review 4.  The role of magnesium therapy in acute myocardial infarction.

Authors:  L E Rabbani; E M Antman
Journal:  Clin Cardiol       Date:  1996-11       Impact factor: 2.882

Review 5.  Magnesium sulfate therapy in certain emergency conditions.

Authors:  M A Frakes; L E Richardson
Journal:  Am J Emerg Med       Date:  1997-03       Impact factor: 2.469

Review 6.  Magnesium in acute myocardial infarction: still an open question.

Authors:  M S Seelig; R J Elin; E M Antman
Journal:  Can J Cardiol       Date:  1998-05       Impact factor: 5.223

7.  Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

Authors:  K L Woods; S Fletcher; C Roffe; Y Haider
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

8.  ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1995-03-18       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.